Clinical Trial Update: Continuous Hyperosomolar Therapy for Traumatic Brain-injured Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update on continuous hyperosmolarm therapy in moderate to severe traumatic brain injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• To Severe Traumatic Brain Injury
• Traumatic Brain Injury

Snippet

Sponsor: Nantes University Hospital | Conditions: Moderate to Severe Traumatic Brain Injury | Phase 3 | Status: COMPLETED